According to GuruFocus Insider Data, the recent CFO sells were:Â Google Inc, Forest Laboratories Inc, Facebook Inc and Gilead Sciences Inc.Â
Google Inc. (GOOG, Financial): SVP & CFO Patrick Pichette sold 742 Shares
On 12/12/2013, SVP & CFO Patrick Pichette sold 742 shares at an average price of $1077.75. The price of the stock has increased by 9.58% since. Google Inc. has a market cap of $394.55 billion and its shares were traded at around $1180.97. The company has a P/E ratio of 31.00 and P/S ratio of 6.75. Over the past 10 years, Google Inc. had an annual average earnings growth of 44.30%; GuruFocus rated Google, Inc. the business predictability rank of 2.5-star.
Google Inc. announced their 2013 third quarter results with revenues of $13.89 billion with a gross profit of $8.48 billion; the net income was $2.97 billion. The total revenue of Google Inc. in 2012 was $50.18 billion, a 32% increase from the 2011 total revenue. The 2012 gross profit was $12.76 billion, a 9% increase from the 2011 gross profit; the 2012 net income was $10.74 billion.
On 01/17/2014, CEO and 10% Owner Lawrence Page sold 16,670 shares at an average price of $1153.99. The price of the stock has increased by 2.34% since. On 01/16/2014, Lawrence Page sold 33,332 shares at an average price of $1151.75. On 01/27/2014, Executive Chairman of Board Eric E Schmidt sold 2,008 shares at an average price of $1093.95. The price of the stock has increased by 7.95% since.
Forest Laboratories Inc. (FRX, Financial): EVP Finance & Admin. & CFO Perier I Francis Jr. sold 12,000 Shares
On 08/21/2013, EVP Finance & Admin. & CFO Perier I Francis Jr. sold 12,000 shares at an average price of $43.00. The price of the stock has increased by 54.19% since. Forest Laboratories Inc has a market cap of $17.86 billion and its shares were traded at around $66.30; the company has a P/S ratio of 5.49.
Forest Laboratories Inc. announced their 2013 third quarter results with revenues of $847.45 million with a gross profit of $683.7 million; the net income was $69.98 million. The company had 2013 total revenues of $3.1 billion, a 32% decrease from the 2012 total revenue. The 2013 gross profit was $2.4 billion, a 31% decrease from the 2012 gross profit; the 2013 net income was $32.1 million.
On 08/26/2013, Director Lawrence S Olanoff sold 1,104 shares at an average price of $42.96. The price of the stock has increased by 54.33% since. On 01/22/2014, SVP-Sales Jerome Lynch sold 135,625 shares at an average price of $67.28. The price of the stock has decreased by 1.46% since. On 01/27/2014, Director Howard Solomon sold 250,000 shares at an average price of $65.41. The price of the stock has increased by 1.36% since.
Facebook Inc. (FB, Financial): CFO David A Ebersman sold 23,400 Shares
On 01/23/2014, CFO David A Ebersman sold 23,400 shares at an average price of $57.59. The price of the stock has increased by 8.65% since. Facebook Inc. has a market cap of $153.8 billion and its shares were traded at around $62.57. The company has a P/E ratio of 155.20 and P/S ratio of 23.98.
Facebook Inc. announced their 2013 third quarter results with revenues of $2.015 billion with a gross profit of $1.5 billion; the net income was $422 million. The 2012 total revenue of Facebook Inc. was $5.09 billion, a 37% increase from the 2011 total revenue. The gross profit for 2012 was $3.72 billion, a 31% increase from the 2011 gross profit; the 2012 net income was $32 million.
Â
On 01/29/2014, Chief Accounting Officer Jas Athwal sold 500 shares at an average price of $54.6. The price of the stock has increased by 14.6% since. On 01/28/2014, COO Sheryl Sandberg sold 283,334 shares at an average price of $54.74. The price of the stock has increased by 14.3% since. On 01/27/2014, Chief Technology Officer Michael Todd Schroepfer sold 25,000 shares at an average price of $54.69. The price of the stock has increased by 14.41% since.
Gilead Sciences Inc. (GILD, Financial): SVP, CFO Robin L Washington sold 35,600 Shares
On 01/02/2014, SVP, CFO Robin L Washington sold 35,600 shares at an average price of $75.03. The price of the stock has increased by 7.49% since. Gilead Sciences Inc. has a market cap of $123.66 billion and its shares were traded at around $80.65. The company has a P/E ratio of 44.20 and P/S ratio of 12.66; over the past 5 years, Gilead Sciences Inc. had an annual average earnings growth of 14.80%.
Gilead Sciences Inc. announced their 2013 third quarter results with revenues of $2.78 billion with a gross profit of $2.1 billion; the net income was $788.6 million. In 2012, the company had total revenues of $9.7 billion, a 16% increase from the 2011 total revenue. The 2012 gross profit was $7.2 billion, a 15% increase from the 2011 gross profit; the 2012 net income was $2.6 billion.
On 01/23/2014, EVP, Commercial Operations Kevin Young sold 100,000 shares at an average price of $81.44. The price of the stock has decreased by 0.97% since. On 01/21/2014, EVP, Corp & Med Affairs Gregg H Alton sold 120,000 shares at an average price of $80. The price of the stock has increased by 0.81% since. On 01/02/2014, Chairman and CEO John C. Martin sold 140,625 shares at an average price of $75.02. The price of the stock has increased by 7.5% since.Â
